MedTrace Logo

Intravenous Antibiotic Treatment at Home

NCT04898452 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-06-22

No results posted yet for this study

Summary

The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.

Conditions

Interventions

OTHER

A new model of interaction across health services with use of welfare technology and telemedicine

Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.

Sponsors & Collaborators

  • SINTEF Health Research

    collaborator OTHER

  • Kristiansund municipality

    collaborator UNKNOWN

  • Centre for Health Innovation

    collaborator UNKNOWN

  • Hospital Pharmacy of Central Norway Trust

    collaborator UNKNOWN

  • Helse Møre og Romsdal HF

    lead OTHER_GOV

Principal Investigators

  • Torstein Hole, md phd · Møre og Romsdal Hospital Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-02
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04898452 on ClinicalTrials.gov